VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares hit a new 52-week low on Tuesday . The stock traded as low as C$0.09 and last traded at C$0.09, with a volume of 340510 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Stock Down 5.6 %
The company has a current ratio of 0.28, a quick ratio of 6.67 and a debt-to-equity ratio of 217.41. The firm has a market capitalization of C$13.36 million, a PE ratio of -2.83 and a beta of 0.39. The firm has a 50-day moving average of C$0.10 and a two-hundred day moving average of C$0.14.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Articles
- Five stocks we like better than VentriPoint Diagnostics
- What Investors Need to Know About Upcoming IPOs
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- Canadian Penny Stocks: Can They Make You Rich?
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- Energy and Oil Stocks Explained
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
